Document Type : Original Article

Authors

1 Department of Pediatrics, School of Medicine, Hazrat-e Fateme Masoume Hospital, Qom University of Medical Sciences, Qom, Iran

2 Department of Family and Community Medicine, School of Medicine, Spiritual Health Research Center, Qom University of Medical Sciences, Qom, Iran

3 Student Research Committee, School of Medicine, Qom University of Medical Sciences, Qom, Iran

Abstract

 Background: Congenital heart defects (CHDs) are a major cause of death and illness in newborns. Early detection is vital for prompt treatment and better outcomes. This study explored the effectiveness of first-trimester ultrasound in identifying CHDs and its association with increased nuchal translucency (NT), tricuspid regurgitation (TR), and abnormal ductus venosus (DV) flow.
Methods: This cross-sectional study involved all pregnant women who had first-trimester screening ultrasounds performed by an obstetrician or radiologist at Forghani Hospital between 2017 and 2024. These women were subsequently referred for fetal echocardiography at 16-18 weeks of gestation at Hazrat Masoumeh Hospital in Qom, Iran. Postnatal neonatal echocardiography was conducted for all cases. The study calculated the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of increased nuchal translucency (NT), tricuspid regurgitation (TR), and abnormal ductus venosus (DV) flow in detecting congenital heart defects (CHDs).
Results: The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of increased nuchal translucency (NT) for detecting congenital heart defects (CHDs) were 74.7%, 98.3%, 90.9%, and 94.7%, respectively. For tricuspid regurgitation (TR), these values were 71.9%, 97.7%, 87.5%, and 94.1%, respectively. Regarding abnormal ductus venosus (DV) flow, the values were 82.2%, 95.1%, 78.5%, and 96.1%, respectively. The diagnostic accuracy for detecting CHDs using NT, TR, and abnormal DV flow was 94.1%, 93.1%, and 92.8%, respectively.
Conclusion: Targeted fetal ultrasound in the first trimester is a valuable diagnostic tool for detecting CHDs. Early detection can contribute to improved neonatal outcomes.

Keywords

Main Subjects

  1. Liu Y, Chen S, Zühlke L, Black GC, Choy MK, Li N, et al. Global birth prevalence of congenital heart defects 1970- 2017: updated systematic review and meta-analysis of 260 studies. Int J Epidemiol. 2019;48(2):455-63. doi: 10.1093/ije/ dyz009.
  2. Souka AP, Snijders RJ, Novakov A, Soares W, Nicolaides KH. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation. Ultrasound Obstet Gynecol. 1998;11(6):391-400. doi: 10.1046/j.1469-0705.1998.11060391.x.
  3. Syngelaki A, Chelemen T, Dagklis T, Allan L, Nicolaides KH. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11-13 weeks. Prenat Diagn. 2011;31(1):90- 102. doi: 10.1002/pd.2642.
  4. Syngelaki A, Hammami A, Bower S, Zidere V, Akolekar R, Nicolaides KH. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2019;54(4):468-76. doi: 10.1002/uog.20844.
  5. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population-based cohort study. BMJ. 1999;318(7176):81-5. doi: 10.1136/ bmj.318.7176.81.
  6. Ghi T, Huggon IC, Zosmer N, Nicolaides KH. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol. 2001;18(6):610-4. doi: 10.1046/j.0960- 7692.2001.00584.x.
  7. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol. 1999;14(5):307-10. doi: 10.1046/j.1469-0705.1999.14050307.x.
  8. Maiz N, Plasencia W, Dagklis T, Faros E, Nicolaides K. Ductus venosus Doppler in fetuses with cardiac defects and increased nuchal translucency thickness. Ultrasound Obstet Gynecol. 2008;31(3):256-60. doi: 10.1002/uog.5262.
  9. Martínez JM, Comas M, Borrell A, Bennasar M, Gómez O, Puerto B, et al. Abnormal first-trimester ductus venosus blood flow: a marker of cardiac defects in fetuses with normal karyotype and nuchal translucency. Ultrasound Obstet Gynecol. 2010;35(3):267-72. doi: 10.1002/uog.7544.
  10. Chelemen T, Syngelaki A, Maiz N, Allan L, Nicolaides KH. Contribution of ductus venosus Doppler in first-trimester screening for major cardiac defects. Fetal Diagn Ther. 2011;29(2):127-34. doi: 10.1159/000322138.
  11. Pereira S, Ganapathy R, Syngelaki A, Maiz N, Nicolaides KH. Contribution of fetal tricuspid regurgitation in first-trimester screening for major cardiac defects. Obstet Gynecol. 2011;117(6):1384-91. doi: 10.1097/ AOG.0b013e31821aa720.
  12. Wong ND. Epidemiological studies of CHD and the evolution of preventive cardiology. Nat Rev Cardiol. 2014;11(5):276-89. doi: 10.1038/nrcardio.2014.26.
  13. Arjmandnia MH, Yousefi M, Rezvan S, Vahedian M, Noori E, Mohammadi A, et al. Evaluation of congenital heart diseases in neonates with diabetic mothers who referred to teaching hospitals in Qom, Iran. Journal of Vessels and Circulation. 2020;1(1):33-6. doi: 10.21859/JVesselCirc.1.1.33.
  14. Vahedian M, Yousefi M, Mohammadi A, Rezvan S, Noori E, Rezaei G, et al. Evaluation of referral indications for fetal echocardiography in pregnant women referred to Echocardiography unit of Masoumeh Hospital in the winter of 2018. Jundishapur Sci Med J. 2019;18(4):369-77.
  15. Khadir Sharabiany V, Oraii S. Comparison of the effect of the sites of right ventricular pacing on the development of mitral and tricuspid regurgitation. J Arak Univ Med Sci. 2013;16(3):20-5. [Persian].
  16. Mehralizadeh S, Mirmohammmadkhani M, Kalantarzade A. Efficacy and complications of oral ibuprofen and intravenous acetaminophen in closure of patent ductus arteriosus of preterm neonates. Tehran Univ Med J. 2019;77(8):491-7. [Persian].
  17. Baś-Budecka E, Perenc M, Sieroszewski P. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects]. Ginekol Pol. 2010;81(4):272-6.
  18. Borrell A, Grande M, Bennasar M, Borobio V, Jimenez JM, Stergiotou I, et al. First-trimester detection of major cardiac defects with the use of ductus venosus blood flow. Ultrasound Obstet Gynecol. 2013;42(1):51-7. doi: 10.1002/uog.12349.
  19. Minnella GP, Crupano FM, Syngelaki A, Zidere V, Akolekar R, Nicolaides KH. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus. Ultrasound Obstet Gynecol. 2020;55(5):637-44. doi: 10.1002/uog.21956.
  20. Karadzov Orlic N, Egic A, Damnjanovic-Pazin B, Lukic R, Joksic I, Mikovic Z. Screening performance of congenital heart defects in first trimester using simple cardiac scan, nuchal translucency, abnormal ductus venosus blood flow and tricuspid regurgitation. Congenit Heart Dis. 2019;14(6):1094- 101. doi: 10.1111/chd.12852.
  21. Savoia F, Scala C, Coppola M, Riemma G, Vitale SG, Mikuš M, et al. The diagnostic performance of the ductus venosus for the detection of cardiac defects in the first trimester: a systematic review and diagnostic test accuracy meta-analysis. Arch Gynecol Obstet. 2023;308(2):435-51. doi: 10.1007/ s00404-022-06812-w.
  22. Turan S, Goetzinger KR. First-trimester fetal heart evaluation: time to move forward. Ultrasound Obstet Gynecol. 2021;57(5):677-80. doi: 10.1002/uog.23572.
  23. Karim JN, Bradburn E, Roberts N, Papageorghiou AT. First-trimester ultrasound detection of fetal heart anomalies: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2022;59(1):11-25. doi: 10.1002/uog.23740.